Despite the multiple ongoing and novel initiatives for developing brain-targeted drug
delivery systems, insurmountable obstacles remain. A perfect drug delivery device that can …

Colorectal cancer (CRC) has the second highest mortality rate among all cancers
worldwide. Surgery, chemotherapy, radiotherapy, molecular targeting and other treatment …

Extracellular vesicles (EVs) are increasingly tested as therapeutic vehicles and biomarkers,
but still EV subtypes are not fully characterised. To isolate EVs with few co‐isolated entities …

Nanomaterials have been extensively utilized in the fabrication of a wide range of
biosensors for the diagnostics of cancerous and non-cancerous diseases. Owing to their …

Neurodegenerative diseases constitute a group of pathologies whose etiology remains
unknown in many cases, and there are no treatments that stop the progression of such …

Extracellular vesicles (EVs) are nanoparticles (30 to 1000 nm in diameter) surrounded by a
lipid-bilayer which carry bioactive molecules between local and distal cells and participate in …

Extracellular vesicles (EVs) are naturally phospholipid enclosed nanovesicles released by
many cells in the body. They are stable in circulation, have low immunogenicity, and act as …

Exosomes-the natural nanoparticles belonging to heterogeneous vesicles are released via
nearly all sorts of cells, including tumour cells, to oprate intercellular communication …

Research into extracellular vesicles (EVs) has grown significantly over the last few decades
with EVs being widely regarded as a source of biomarkers for human health and disease …

Extracellular vesicles (EVs) are a versatile group of cell-secreted membranous
nanoparticles present in body fluids. They have an exceptional diagnostic potential due to …